It was lovely to speak to our Expert Faculty member, Su Lwin (King’s College London, London, UK), about the development and clinical application of gene and cell therapy for individuals with epidermolysis bullosa.
Questions
- Could you give us a brief overview of epidermolysis bullosa (EB) and the unmet needs in its treatment? (0:20)
- What have been the latest advances in gene therapy for EB? (3:14)
Part 2 of our discussion can be viewed here.
Disclosures: Su Lwin had nothing to disclose in relation to this video.
Support: Interview and filming supported by Touch Medical Media.